GB201520189D0 - Compound for use - Google Patents

Compound for use

Info

Publication number
GB201520189D0
GB201520189D0 GBGB1520189.0A GB201520189A GB201520189D0 GB 201520189 D0 GB201520189 D0 GB 201520189D0 GB 201520189 A GB201520189 A GB 201520189A GB 201520189 D0 GB201520189 D0 GB 201520189D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1520189.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Bioscience AS
Original Assignee
Kappa Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Bioscience AS filed Critical Kappa Bioscience AS
Priority to GBGB1520189.0A priority Critical patent/GB201520189D0/en
Publication of GB201520189D0 publication Critical patent/GB201520189D0/en
Priority to PCT/EP2016/077906 priority patent/WO2017085148A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB1520189.0A 2015-11-16 2015-11-16 Compound for use Ceased GB201520189D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1520189.0A GB201520189D0 (en) 2015-11-16 2015-11-16 Compound for use
PCT/EP2016/077906 WO2017085148A1 (en) 2015-11-16 2016-11-16 Composition comprising vitamin k2 or a provitamin thereof for use in the transformation of white adipose tissue to brown adipose tissue, especially to beige adipose tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1520189.0A GB201520189D0 (en) 2015-11-16 2015-11-16 Compound for use

Publications (1)

Publication Number Publication Date
GB201520189D0 true GB201520189D0 (en) 2015-12-30

Family

ID=55132858

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1520189.0A Ceased GB201520189D0 (en) 2015-11-16 2015-11-16 Compound for use

Country Status (2)

Country Link
GB (1) GB201520189D0 (en)
WO (1) WO2017085148A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011141261A (en) * 2009-03-12 2013-04-20 Виридис Байофарма Пвт Лтд, METHOD OF APPLICATION OF VITAMIN K AS AN ENERGY AMPLIFIER IN VARIOUS PATHOLOGICAL CONDITIONS
NZ613264A (en) * 2010-12-17 2015-05-29 Vitak Bv Use of vitamin k for weight maintenance and weight control
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.

Also Published As

Publication number Publication date
WO2017085148A1 (en) 2017-05-26

Similar Documents

Publication Publication Date Title
GB201510019D0 (en) Compounds
GB201514754D0 (en) Compounds
GB201514751D0 (en) Compounds
HK1255832A1 (en) Pyranodipyridine compound
GB201508747D0 (en) Compounds
GB201521524D0 (en) Compound
GB201518365D0 (en) Compounds
GB201508864D0 (en) Compounds
GB201510493D0 (en) Compounds
PT3331885T (en) Compounds
GB201520419D0 (en) Compounds
GB201518950D0 (en) Compound
GB201508857D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
HK1251574A1 (en) Tetrahydrooxepinopyridine compound
GB201520189D0 (en) Compound for use
GB201521440D0 (en) Compounds
GB201520393D0 (en) Compound
GB201520391D0 (en) Compound
GB201519969D0 (en) Compounds
GB201519965D0 (en) Compounds
GB201519549D0 (en) Compounds
GB201519212D0 (en) Compounds
GB201519213D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)